Chengbin Hu

488 total citations
14 papers, 334 citations indexed

About

Chengbin Hu is a scholar working on Molecular Biology, Surgery and Computer Networks and Communications. According to data from OpenAlex, Chengbin Hu has authored 14 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Computer Networks and Communications. Recurrent topics in Chengbin Hu's work include Cancer-related gene regulation (3 papers), Muscle Physiology and Disorders (2 papers) and Epigenetics and DNA Methylation (2 papers). Chengbin Hu is often cited by papers focused on Cancer-related gene regulation (3 papers), Muscle Physiology and Disorders (2 papers) and Epigenetics and DNA Methylation (2 papers). Chengbin Hu collaborates with scholars based in China, United States and Russia. Chengbin Hu's co-authors include Tommy Chin, Kaiqi Xiong, Lizi Wu, Yumei Gu, Shuibin Lin, Huangxuan Shen, Ruli Gao, Frederic J. Kaye, Chunxia Cao and Zirong Chen and has published in prestigious journals such as Journal of Biological Chemistry, JNCI Journal of the National Cancer Institute and Oncogene.

In The Last Decade

Chengbin Hu

14 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengbin Hu China 9 123 79 72 68 65 14 334
Hao Dai China 10 90 0.7× 99 1.3× 50 0.7× 39 0.6× 16 0.2× 51 365
Kun Peng China 11 101 0.8× 17 0.2× 26 0.4× 41 0.6× 15 0.2× 38 339
Asoke K. Talukder India 8 145 1.2× 54 0.7× 45 0.6× 8 0.1× 22 0.3× 29 364
Tae‐Beom Kim United States 11 45 0.4× 39 0.5× 21 0.3× 54 0.8× 46 0.7× 19 249
Bing‐Chang Chen Taiwan 9 115 0.9× 64 0.8× 27 0.4× 13 0.2× 11 0.2× 12 311
Zahid Nawaz India 9 182 1.5× 50 0.6× 22 0.3× 11 0.2× 11 0.2× 10 430
Tiancheng Xie China 12 180 1.5× 29 0.4× 121 1.7× 32 0.5× 5 0.1× 32 490
Ling Yu China 11 133 1.1× 43 0.5× 12 0.2× 17 0.3× 6 0.1× 37 443
Yuxin Zheng China 5 143 1.2× 15 0.2× 169 2.3× 18 0.3× 27 0.4× 11 314

Countries citing papers authored by Chengbin Hu

Since Specialization
Citations

This map shows the geographic impact of Chengbin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengbin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengbin Hu more than expected).

Fields of papers citing papers by Chengbin Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengbin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengbin Hu. The network helps show where Chengbin Hu may publish in the future.

Co-authorship network of co-authors of Chengbin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengbin Hu. A scholar is included among the top collaborators of Chengbin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengbin Hu. Chengbin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Li, Wenting, Qian Li, Yiqi Jiang, et al.. (2025). The Dual Role and Therapeutic Implications of the Wnt/β-Catenin Pathway in Diabetic Kidney Disease. International Journal of General Medicine. Volume 18. 2757–2768. 1 indexed citations
2.
Zhang, Wenjie, Banghua Wu, Chengbin Hu, et al.. (2025). EGFR and CYP signaling disruption underlies 6PPD-quinone hepatotoxicity: Insights from a network and machine learning approach. Toxicology. 517. 154235–154235. 1 indexed citations
3.
Peng, Jie, Liang Lv, Yuqian Zhou, Xuehong Wang, & Chengbin Hu. (2024). PHAX enhanced LIN28B‐mediated PBX3 mRNA stability to promote esophageal cancer development. Cancer Science. 116(3). 808–823. 1 indexed citations
4.
Zhou, Xihong, Yuting Jiang, Yi‐Jan Emery Chen, et al.. (2023). [Clinical analysis of 86 cases of acute fatty liver of pregnancy].. PubMed. 58(12). 896–902. 2 indexed citations
5.
Zi, Dan, Qing Li, Cheng‐Xiong Xu, et al.. (2022). CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma. Aging. 14(11). 4673–4698. 13 indexed citations
6.
Zajac‐Kaye, Maria, Lizi Wu, Frederic J. Kaye, et al.. (2020). Role of LKB1-CRTC1 on Glycosylated COX-2 and Response to COX-2 Inhibition in Lung Cancer. UNC Libraries. 1 indexed citations
7.
Xiong, Kaiqi, et al.. (2019). A Machine Learning Framework for Domain Generation Algorithm-Based Malware Detection. IEEE Access. 7. 32765–32782. 65 indexed citations
8.
Chin, Tommy, Kaiqi Xiong, & Chengbin Hu. (2018). Phishlimiter: A Phishing Detection and Mitigation Approach Using Software-Defined Networking. IEEE Access. 6. 42516–42531. 46 indexed citations
9.
Zhou, Shu‐Feng, Yi Zhang, Zhiwei Zhou, et al.. (2015). Schisandrin B inhibits cell growth and induces cellular apoptosis and autophagy in mouse hepatocytes and macrophages: implications for its hepatotoxicity. Drug Design Development and Therapy. 9. 2001–2001. 23 indexed citations
10.
Cao, Chunxia, Ruli Gao, Min Zhang, et al.. (2014). Role of LKB1-CRTC1 on Glycosylated COX-2 and Response to COX-2 Inhibition in Lung Cancer. JNCI Journal of the National Cancer Institute. 107(1). 358–358. 37 indexed citations
11.
Gu, Yumei, Chengbin Hu, Jian‐Liang Li, et al.. (2013). Aberrantly activated AREG–EGFR signaling is required for the growth and survival of CRTC1–MAML2 fusion-positive mucoepidermoid carcinoma cells. Oncogene. 33(29). 3869–3877. 71 indexed citations
12.
Lin, Shuibin, Huangxuan Shen, Jian‐Liang Li, et al.. (2013). Proteomic and Functional Analyses Reveal the Role of Chromatin Reader SFMBT1 in Regulating Epigenetic Silencing and the Myogenic Gene Program*. Journal of Biological Chemistry. 288(9). 6238–6247. 24 indexed citations
13.
Lin, Shuibin, Huangxuan Shen, Baofeng Jin, et al.. (2013). Brief Report: Blockade of Notch Signaling in Muscle Stem Cells Causes Muscular Dystrophic Phenotype and Impaired Muscle Regeneration. Stem Cells. 31(4). 823–828. 40 indexed citations
14.
Chen, Zirong, Shuibin Lin, Xiumei Lin, et al.. (2012). DNA methyltransferase inhibitor CDA-II inhibits myogenic differentiation. Biochemical and Biophysical Research Communications. 422(3). 522–526. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026